Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
72.23
-0.50 (-0.69%)
At close: Aug 13, 2025, 4:00 PM
71.56
-0.67 (-0.93%)
After-hours: Aug 13, 2025, 4:10 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $2.37 billion as of August 13, 2025. Its market cap has increased by 60.58% in one year.
Market Cap
2.37B
Enterprise Value
2.20B
1-Year Change
60.58%
Ranking
Category
Stock Price
$72.23
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $2.37B, an increase of 1,540.40%. That is a compound annual growth rate of 133.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 2.35B | 20.58% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |